Under the new policy, all intramural research, or research conducted within the National Institutes of Health (NIH), involving the use of human fetal tissue from elective abortions, will be discontinued. Extramural research projects funded by NIH grants involving aborted fetal tissue will be required to go through an additional review process convened by an ethics advisory board.
The letter reads in part: “Decades of thoughtful deliberation on fetal tissue research has provided an ethical and regulatory framework for valuable medical research to progress, enabling the discovery of therapies that would not otherwise have been possible. The ethical considerations fall heavily in favor of permitting fetal tissue research, conducted in accordance with longstanding federal rules. The new restrictions on NIH intramural research using fetal tissue and the new redundant ethics reviews for extramural research will disrupt important biomedical research and delay the development of new treatments for patients.”
Read the letter here: https://www.aibs.org/position-statements/20190711_multi-society_l_3.html